[1] Low G, Alexander GJ, Lomas DJ. Hepatorenal syndrome: actiology, diagnosis, and treatment[J]. Gastroenterol Res Pract, 2015, 2015:207012.
[2] Tandon P, Garcia-Tsao G. Renal dysfunction is the most important independent predictor of omortality in cirrhotic patients withspontaneous bacterial peritonitis[J]. Clin Gastroenterol Hepatol, 2011, 9(3):260-265.
[3] Belcher JM, Garcia-Tsao G, Sanyal AJ, et al. Association of AKI with mortality and complications in hospitalized patients withcirrhosis[J]. Hepatology, 2013, 57(2):753-762.
[4] 中华医学会肝病学分会 . 肝硬化腹水及相关并发症的诊疗指南[J]. 传染病信息,2017,30(5):158-174.
[5] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组 . 肝衰竭诊治指南[J]. 临床肝胆病杂志,2019,35(1):38-44.
[6] Myers GL, Miller WG, Coresh J, et al. Recommendations for improving serum creatinine measurement: a report from theLaboratory Working Group of the National Kidney DiseaseEducation Program[J]. Clin Chem, 2006, 52(1):5-18.
[7] Levey AS, Stevens LA, Sehmid CH, et al. A new equation to estimate glomerular filtration rate[J]. Ann Intern Med, 2009, 150(9):604-612.
[8] Stevens LA, Claybon MA, Schmid CH, et al. Evaluation of the CKD-EPI equations in multiple races and ethnicities[J]. KidneyInt, 2011, 79(5):555-562.
[9] Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerularfiltration rate from serum creatinine and cystatin C[J]. N Enql J Med, 2012, 367(1):20-29.
[10] Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR usingserum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3418 individuals with CKD[J]. Am J Kidney Dis, 2008, 51(3):395-406.
[11] 全国课题协作组 . MDRD方程在我国慢性肾脏病患者中的改良和评估[J]. 中国肾脏病杂志,2006,22(10):589-595.
[12] 吴锡信 . 基于血清胱抑素 C的成年中国人肾小球滤过率估算公式临床对比研究[J]. 中国危重病急救医学,2012, 24(9):530-533.
[13] Ma YC, Zuo L, Chen JH, et al. Improved GFR estimation bycombined creatinine and cystatin C measurements[J]. Kidney Int, 2007, 72(12):1535-1542.
[14] 李红艳 . ROC曲线评价血清胱抑素 C对早期肾功能损伤的临床诊断价值[J]. 中国实验诊断学,2017,21(6):958-960.
[15] Wei L, Ye X. Diagnostic accuracy of serum cystatin C in chronickidney disease: a meta-analysis[J]. Clin Nephrol, 2015, 84(2):86.
[16] 臧红,郭建民,辛红霞,等 . 血清胱抑素 C在 HBV相关慢加急性肝衰竭患者中的临床意义[J]. 中华试验和临床病毒学杂志,2017,31(4):338-342.
[17] Nadim MK, Kellum JA, Davenport A, et al. Hepatorenal syndrome: The 8th international consensus conference of the acute dialysisquality initiative(ADQI) group[J]. Crit Care, 2012, 16(1):R23.
[18] Wan ZH, Wang JJ, You SL, et al. Cystatin is biomarker forpredicting acute kidney injury in patients with acute-on-chronicliver failure[J]. World Gastroenterol, 2013, 19(48):9432-9438.